Literature DB >> 30273242

Brain and Spinal Epidural Abscess.

Felicia Chow.   

Abstract

PURPOSE OF REVIEW: Brain abscesses and spinal epidural abscesses are serious, potentially life-threatening infections of the central nervous system. This article outlines the clinical presentation, evaluation, and management of brain abscesses and spinal epidural abscesses, with a specific focus on bacterial infections. RECENT
FINDINGS: The overall incidence of brain abscesses has declined, in part because of fewer brain abscesses associated with otogenic infections. However, emerging patient populations at high risk for brain abscess include those with a history of penetrating head trauma, neurosurgery, or immunodeficiency. Improved mortality rates for brain abscess are attributable to modern diagnostic imaging, stereotactic-guided aspiration, and newer antimicrobials that readily penetrate into the central nervous system and abscesses. Brain MRI is more sensitive than CT for brain abscess, particularly in the early stages, but CT remains more widely available and can adequately identify potential abscesses and confirm response to treatment. With the advent of minimally invasive neurosurgical techniques, surgical excision is often employed only for posterior fossa, multiloculated, or superficial well-circumscribed abscesses. In select clinical scenarios, conservative medical management may be a safe alternative to a combined surgical and medical approach. Unlike brain abscess, the incidence of spinal epidural abscess is on the rise and has been attributed to higher prevalence of predisposing factors, including spinal procedures and instrumentation.
SUMMARY: Successful diagnosis and management of brain abscess and spinal epidural abscess requires a collaborative approach among neurologists, neurosurgeons, radiologists, and infectious disease physicians. The foundation of management of brain abscess includes surgical intervention for diagnostic purposes if a pathogen has not been identified or for decompression of larger abscesses or those with mass effect and significant surrounding edema; appropriate dosing and adequate duration of an antimicrobial regimen tailored to the presumptive source of infection and available culture data, and eradication of the primary source of infection. For spinal epidural abscesses, neurologic status at the time of presentation is directly related to outcomes, underscoring the importance of prompt recognition and intervention.

Entities:  

Mesh:

Year:  2018        PMID: 30273242     DOI: 10.1212/CON.0000000000000649

Source DB:  PubMed          Journal:  Continuum (Minneap Minn)        ISSN: 1080-2371


  6 in total

1.  Time-to-completed-imaging, survival and function in patients with spinal epidural abscess: Description of a series of 34 patients, 2015-2018.

Authors:  Caroline King; Cameron Fisher; Patrick C M Brown; Kelsey C Priest; Mary Tanski; Peter Sullivan
Journal:  BMC Health Serv Res       Date:  2020-02-14       Impact factor: 2.655

Review 2.  HIV-Related Cerebral Toxoplasmosis Revisited: Current Concepts and Controversies of an Old Disease.

Authors:  José Ernesto Vidal
Journal:  J Int Assoc Provid AIDS Care       Date:  2019 Jan-Dec

3.  Outcome of medical treatment of otogenic brain abcess without therapeutic drainage: A case of central vertigo.

Authors:  Soni Azhar Pribadi; Aan Dwi Prasetio; Putri Irsalina; Wardah Rahmatul Islamiyah; Paulus Sugianto
Journal:  Radiol Case Rep       Date:  2022-07-28

4.  Plasma Microbial Cell-Free DNA (CF-DNA) Next-Generation Sequencing in Diagnosing Intracranial Abscesses: Pathophysiology and a Scoping Review of the Literature.

Authors:  Bahadar S Srichawla
Journal:  Cureus       Date:  2022-08-19

5.  A rare case of brain abscess caused by Actinomyces meyeri.

Authors:  Ranjit Sah; Gaurav Nepal; Sanjit Sah; Sonam Singla; Priti Upadhyay; Ali A Rabaan; Kuldeep Dhama; Alfonso J Rodriguez-Morales; Rabindra Ghimire
Journal:  BMC Infect Dis       Date:  2020-05-27       Impact factor: 3.090

6.  Brain abscess in a patient with psoriatic arthritis treated with adalimumab: A case report.

Authors:  Yu-Pei Lo; Snehal Desale; Po-Yuan Wu
Journal:  Medicine (Baltimore)       Date:  2020-03       Impact factor: 1.889

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.